This section considers submissions that focus on research relating to novel chemical entity design, screening and delivery.
Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
Levamlodipine, a calcium channel blocker, has been show act as a cardiovascular drug. To compare the pharmacokinetic parameters between levamlodipine (test formulation) at a single dose of 5 mg and amlodipine ...
Citation: BMC Pharmacology and Toxicology 2020 21:80